SMAcademy learning opportunities & webinars

Upcoming

SMA Europe, in collaboration with SMAcademy, our patient advocate capacity-building initiative, is happy to invite you to the webinar: 

“Present and Future of Gene Therapy” on 19 of February 2026 from 16.00 to 17.30 CET.  

Speaker 

  • Dr. Serge Braun, PharmD, PhD. Advisor to the Presidency, former Chief Scientific Officer, AFM-Telethon, Evry, France (2005-2025). Director Neuromuscular Diseases Strategy at Genethon, Evry. Member of the French National Academy of Pharmacy. He dedicated his entire carrier to rare diseases, including neuromuscular diseases, and has gained an extensive 30 year-experience in gene therapies. 

Summary  

 
The webinar will explore the evolving field of gene therapy and its application in the treatment of SMA and beyond. It will provide insights into the historical milestones of gene therapy, how it works biologically, current applications, and the potential future of disease-modifying strategies.
 
The introduction of disease-modifying treatments (DMTs), which target the genetic causes of SMA, has transformed the clinical landscape. In this webinar, we will examine the biological and clinical differences among currently available DMTs and discuss next-generation gene therapies currently in development.
Register here

Webinars:

Workshops: